期刊文献+

心房纤颤病人B型利钠肽变化与护理要点 被引量:5

Change of b-type natriuretic peptide in patients with atrial fibrillation and related nursing
下载PDF
导出
摘要 目的测定心房纤颤(房颤)病人血B型利钠肽(BNP)水平并探讨其护理要点。方法抽静脉血化验45例住院房颤病人的血B型利钠肽,并与35例非房颤病例对照;2组病人采取不同级别的护理措施。结果房颤组病人血BNP水平较对照组明显升高[(161±119)pg/ml和(89±64)pg/ml,t=4.87,P<0.01];2组病人对护理工作满意者分别有(43/45)例和(30/35)例,2组对比无显著性差异,(P>0.05)。结论房颤病人血BNP水平会增高,护理工作者应了解这些变化,并应用于护理实践中。 Objective To measure blood natriuretic peptide(BNP) of patients with atrial fibrillation and explore the related nursing. Methods Forty-five inpatients with atrial fibrillation(atrial fibrillation group) and thirty-five patients of sinus rhythm inpatients(control group) were measured blood BNP. Their nursing measures were performed differently. Results Average blood BNP concentration of atrial fibrillation group was significantly higher than that of sinus rhythm group[(161±119)pg/ml and (89±64)pg/ml, t = 4.87 ,P〈 0. 0011 . The number of patients who were satisfied with nursing in atrial fibrillation group and control group were 43 and 30 cases respectively, but no statistical difference (P 〉 0.05). Conclusions Blood BNP concentration of patients with atrial fibrillation is increased, so nurses should master the knowledge and take care of the patients comprehensively.
出处 《现代护理》 2006年第5期422-423,共2页 Modern Nursing
关键词 B型利钠肽 心房纤颤 护理 B-type natriuretic peptide Atrial fibrillation Nursing
  • 相关文献

参考文献9

二级参考文献89

  • 1罗静.预激综合征合并快速房颤的急诊救治[J].中国实用内科杂志,1994,14(2):84-85. 被引量:8
  • 2林修功.预激综合征并发心房颤动或心房扑动治疗的经验[J].中国实用内科杂志,1994,14(8):459-461. 被引量:1
  • 3Van Cheng BS, Kazanegra R, Garcia A,et al. A rapid bedside test for B-type natriuretic peptide predicts treatment outcomes in patients admitted with decompensated heart failure[J]. J Am Coll Cardiol, 2001,37:386-391.
  • 4Grantham JA, Burnett JC. BNP, Increasing importance in the pathophysiology and diagnosis of congestive heart failure[J]. Circulation, 1997,96:388-390.
  • 5Mann DL. Mechanisms and models of heart failure : A combinatorial approach[J]. Circulation, 1999,100 : 999-1008.
  • 6Kazanegra R, Van Cheng BS, Garcia A,et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure:Apilot study[J]. J Cardiac Fail, 2001, 7:21-29.
  • 7Maeda K, Tsutamoto T, Wada A,et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure[J]. J Am Coil Cardiol, 2000,36:1587-1593.
  • 8Richards AM, Doughty R, Nicholls MG,et al. for the Australia-New Zealand Heart Failure Group: Neurohumoral predictors of benefit from earvedilol in isehemie left ventricular dysfunction[J]. Circulation, 1999,99: 786-797.
  • 9Troughton RW, Frampton CM, Yandle TG ,et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide concentrations[J]. Lancet, 2000, 355 : 1125-1130.
  • 10Maisel. B-type natriuretic peptide in the diagnosis and management of congestive heart failure [J]. Heart Failure. 2001,19:557-571.

共引文献56

同被引文献27

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部